{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:26:42Z","timestamp":1787160402872,"version":"build-2736575974"},"reference-count":176,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2023.14029","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T02:07:39Z","timestamp":1693188459000},"source":"Crossref","is-referenced-by-count":3,"title":["A pancreatic adenocarcinoma mimicking hepatoid carcinoma of uncertain histogenesis: A case report and literature review"],"prefix":"10.3892","volume":"26","author":[{"given":"Andreea","family":"Iliesiu","sequence":"first","affiliation":[{"name":"Department of Pathology, University Emergency Hospital of Bucharest, Bucharest 014461, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu-Valeriu","family":"Toma","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, Bucharest 050474, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ciongariu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Emergency Hospital of Bucharest, Bucharest 014461, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Costea","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, Bucharest 050474, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcis","family":"Zarnescu","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, Bucharest 050474, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liviu","family":"B\u00eelteanu","sequence":"additional","affiliation":[{"name":"Oncological Institute \u2018Alexandru Trestioreanu\u2019, Bucharest 022328, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"key20230925111246_b1-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"e20051","DOI":"10.1097\/MD.0000000000020051","article-title":"Primary hepatoid carcinoma of the ovary: A case report and review of the literature","volume":"99","author":"Choi","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"key20230925111246_b2-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40792-016-0197-7","article-title":"A hepatoid carcinoma of the pancreatic head","volume":"2","author":"Stamatova","year":"2016","journal-title":"Sur Case Rep"},{"key":"key20230925111246_b3-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/dc.23195","article-title":"Pancreatic hepatoid carcinoma: A rare form of pancreatic neoplasm","volume":"43","author":"Soofi","year":"2015","journal-title":"Diagn Cytopathol"},{"key":"key20230925111246_b4-ol-26-4-14029","first-page":"285","article-title":"Hepatoid microcarcinoma of the pancreas: A case report and review of the literature","volume":"35","author":"Chen","year":"2012","journal-title":"Chang Gung Med J"},{"key":"key20230925111246_b5-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00428-015-1788-6","article-title":"Hepatoid carcinoma of the pancreas with lymphoid stroma: First description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma","volume":"467","author":"Vanoli","year":"2015","journal-title":"Virchows Arch"},{"key":"key20230925111246_b6-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.12998\/wjcc.v8.i6.1116","article-title":"Hepatoid carcinoma of the pancreas: A case report and review of the literature","volume":"8","author":"Zeng","year":"2020","journal-title":"World J Clin Cases"},{"key":"key20230925111246_b7-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"100564","DOI":"10.1016\/j.gore.2020.100564","article-title":"Hepatoid carcinoma of the ovary-A case report and literature review","volume":"32","author":"Uribe Rivera","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"key20230925111246_b8-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"883","DOI":"10.5858\/arpa.2017-0485-RS","article-title":"Hepatoid carcinoma of the ovary: Clinical, histopathologic, and immunophenotypic features","volume":"143","author":"Acosta","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"key20230925111246_b9-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/14737140.2018.1403319","article-title":"Recent advances in the management of pancreatic adenocarcinoma","volume":"18","author":"Karakas","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20230925111246_b10-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14737140.2018.1417844","article-title":"The evolution into personalized therapies in pancreatic ductal adenocarcinoma: Challenges and opportunities","volume":"18","author":"Tesfaye","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20230925111246_b11-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.clinre.2020.101589","article-title":"Microbiome and pancreatic ductal adenocarcinoma","volume":"45","author":"Tijeras-Raballand","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"key20230925111246_b12-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/jso.26415","article-title":"Multidisciplinary management of locally advanced pancreatic adenocarcinoma: Biology is King","volume":"123","author":"Attiyeh","year":"2021","journal-title":"J Surg Oncol"},{"key":"key20230925111246_b13-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/geriatrics3040085","article-title":"The management of older adults with pancreatic adenocarcinoma","volume":"3","author":"Ogden","year":"2018","journal-title":"Geriatrics"},{"key":"key20230925111246_b14-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/diagnostics11030562","article-title":"Pancreatic ductal adenocarcinoma: Epidemiology and risk factors","volume":"11","author":"Ushio","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"key20230925111246_b15-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"107508","DOI":"10.1016\/j.intimp.2021.107508","article-title":"Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview","volume":"95","author":"Panchal","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"key20230925111246_b16-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/jgh.14576","article-title":"A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma","volume":"34","author":"Pang","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"key20230925111246_b17-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2174\/1389202919666180221160753","article-title":"Genetic alterations of periampullary and pancreatic ductal adenocarcinoma: An overview","volume":"19","author":"Sikdar","year":"2018","journal-title":"Curr Genomics"},{"key":"key20230925111246_b18-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3390\/ijms19092468","article-title":"New Hope for pancreatic ductal adenocarcinoma treatment targeting endoplasmic reticulum stress response: A systematic review","volume":"19","author":"Garcia-Carbonero","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20230925111246_b19-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1081\/CNV-100000076","article-title":"The role of genetic factors in the etiology of pancreatic adenocarcinoma: An update","volume":"19","author":"Chappuis","year":"2001","journal-title":"Cancer Inve"},{"key":"key20230925111246_b20-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"563267","DOI":"10.3389\/fendo.2020.563267","article-title":"Interplay between diabetes and pancreatic ductal adenocarcinoma and insulinoma: The role of aging, genetic factors, and obesity","volume":"11","author":"Duvilli\u00e9","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20230925111246_b21-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/110241599750006811","article-title":"Prognosis of human pancreatic adenocarcinoma: Review of clinical and histopathological variables and possible uses of new molecular methods","volume":"165","author":"Eskelinen","year":"1999","journal-title":"Eur J Surg"},{"key":"key20230925111246_b22-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ajpath.2018.06.026","article-title":"Familial pancreatic ductal adenocarcinoma","volume":"189","author":"Diaz","year":"2019","journal-title":"Am J Pathol"},{"key":"key20230925111246_b23-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.3390\/cancers13143431","article-title":"Micro- and mycobiota dysbiosis in pancreatic ductal adenocarcinoma development","volume":"13","author":"Bellotti","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b24-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.3390\/cancers14194589","article-title":"Single cell RNA sequencing: A new frontier in pancreatic ductal adenocarcinoma","volume":"14","author":"Bou Zerdan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b25-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.3390\/ijms22105138","article-title":"Coagulation signaling through PAR1 as a therapeutic target in pancreatic ductal adenocarcinoma","volume":"22","author":"Kothari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20230925111246_b26-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"175883592093303","DOI":"10.1177\/1758835920933034","article-title":"Surgical and local treatment of hepatic metastasis in pancreatic ductal adenocarcinoma: Recent advances and future prospects","volume":"12","author":"Jin","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"key20230925111246_b27-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijsu.2017.10.066","article-title":"Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis","volume":"48","author":"Yu","year":"2017","journal-title":"Int J Surg"},{"key":"key20230925111246_b28-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"188669","DOI":"10.1016\/j.bbcan.2021.188669","article-title":"Acinar to ductal cell trans-differentiation: A prelude to dysplasia and pancreatic ductal adenocarcinoma","volume":"1877","author":"Parte","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"key20230925111246_b29-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cca.2018.11.023","article-title":"Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma","volume":"488","author":"Igbinigie","year":"2019","journal-title":"Clin Chim Acta"},{"key":"key20230925111246_b30-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000522425","article-title":"Pancreatic ductal adenocarcinoma: New insights into the actions of vitamin A","volume":"45","author":"Mere Del Aguila","year":"2022","journal-title":"Oncol Res Treat"},{"key":"key20230925111246_b31-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11864-020-00763-7","article-title":"Targeting DNA damage repair pathways in pancreatic adenocarcinoma","volume":"21","author":"Das","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"key20230925111246_b32-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1159\/000493401","article-title":"Targeting defects in the cellular DNA damage response for the treatment of pancreatic ductal adenocarcinoma","volume":"41","author":"Schmitt","year":"2018","journal-title":"Oncol Res Treat"},{"key":"key20230925111246_b33-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"key20230925111246_b34-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ags3.12436","article-title":"Recent advances in precision medicine for pancreatic ductal adenocarcinoma","volume":"5","author":"Hayashi","year":"2021","journal-title":"Ann Gastroenterol Surg"},{"key":"key20230925111246_b35-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jamaoncol.2019.5963","article-title":"An emerging paradigm for germline testing in pancreatic ductal adenocarcinoma and immediate implications for clinical practice: A review","volume":"6","author":"Rainone","year":"2020","journal-title":"JAMA Oncol"},{"key":"key20230925111246_b36-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.2147\/OTT.S232464","article-title":"Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?","volume":"13","author":"Wu","year":"2020","journal-title":"Onco Targets Ther"},{"key":"key20230925111246_b37-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.ctrv.2022.102357","article-title":"Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients","volume":"104","author":"Macchini","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"key20230925111246_b38-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1159\/000508533","article-title":"Excellent response to olaparib in a patient with metastatic pancreatic adenocarcinoma with germline BRCA1 mutation after progression on FOLFIRINOX: Case report and literature review","volume":"13","author":"Pimenta","year":"2020","journal-title":"Case Rep Oncol"},{"key":"key20230925111246_b39-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"101895","DOI":"10.1016\/j.ctrv.2019.101895","article-title":"Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis","volume":"80","author":"Rebelatto","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"key20230925111246_b40-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1159\/000527692","article-title":"Platinum-Based chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: Summary of evidence and application in clinical practice","volume":"45","author":"Reinacher-Schick","year":"2022","journal-title":"Oncol Res Treat"},{"key":"key20230925111246_b41-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40265-020-01304-0","article-title":"New treatment strategies for metastatic pancreatic ductal adenocarcinoma","volume":"80","author":"Singh","year":"2020","journal-title":"Drugs"},{"key":"key20230925111246_b42-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2217\/pgs-2018-0073","article-title":"Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma","volume":"20","author":"Zemanek","year":"2019","journal-title":"Pharmacogenomics"},{"key":"key20230925111246_b43-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.3390\/ijms21103534","article-title":"SMAD4 and the TGF\u03b2 pathway in patients with pancreatic ductal adenocarcinoma","volume":"21","author":"Dardare","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20230925111246_b44-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2216756","DOI":"10.1080\/08941939.2023.2216756","article-title":"Expression of miR-425-5p in pancreatic carcinoma and its correlation with tumor immune microenvironment","volume":"36","author":"Jian","year":"2023","journal-title":"J Invest Surg"},{"key":"key20230925111246_b45-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.12.025","article-title":"Tumor-stroma TGF-\u03b21-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin \u03b1v\u03b23\/CD36-mediated activation of the MAPK pathway","volume":"528","author":"Nan","year":"2022","journal-title":"Cancer Lett"},{"key":"key20230925111246_b46-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.3390\/cancers13246204","article-title":"TGF\u03b2 drives metabolic perturbations during epithelial mesenchymal transition in pancreatic cancer: TGF\u03b2 induced EMT in PDAC","volume":"13","author":"Rajagopal","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b47-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fphys.2018.00335","article-title":"Phosphoinositide 3-Kinase signaling pathway in pancreatic ductal adenocarcinoma progression, pathogenesis, and therapeutics","volume":"9","author":"Murthy","year":"2018","journal-title":"Front Physiol"},{"key":"key20230925111246_b48-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4240\/wjgs.v11.i3.143","article-title":"Management of pancreatic head adenocarcinoma: From where to where?","volume":"11","author":"Dolay","year":"2019","journal-title":"World J Gastrointest Surg"},{"key":"key20230925111246_b49-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"13408","DOI":"10.3390\/ijms222413408","article-title":"Cancer-Associated fibroblasts in pancreatic ductal adenocarcinoma: An update on heterogeneity and therapeutic targeting","volume":"22","author":"Vaish","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20230925111246_b50-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21037\/cco.2017.12.02","article-title":"Interventional endoscopy in the diagnosis and management of pancreatic adenocarcinoma","volume":"6","author":"Khokhar","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"key20230925111246_b51-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"100638","DOI":"10.1016\/j.esmoop.2022.100638","article-title":"Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?","volume":"7","author":"R\u00e9mond","year":"2022","journal-title":"ESMO Open"},{"key":"key20230925111246_b52-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1002\/cncr.34273","article-title":"Preoperative therapy for pancreatic adenocarcinoma-precision beyond anatomy","volume":"128","author":"Seo","year":"2022","journal-title":"Cancer"},{"key":"key20230925111246_b53-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.3390\/cancers14112577","article-title":"Pancreatic ductal adenocarcinoma: Current and emerging therapeutic uses of focused ultrasound","volume":"14","author":"Lafond","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b54-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3748\/wjg.v27.i13.1283","article-title":"Artificial intelligence for early detection of pancreatic adenocarcinoma: The future is promising","volume":"27","author":"Ladd","year":"2021","journal-title":"World J Gastroenterol"},{"key":"key20230925111246_b55-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"671","DOI":"10.47162\/RJME.62.3.03","article-title":"Prognostic biomarkers related to tumoral microenvironment in pancreatic ductal adenocarcinoma: A systematic review","volume":"62","author":"Constantin","year":"2021","journal-title":"Rom J Morphol Embryol"},{"key":"key20230925111246_b56-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00261-019-02290-y","article-title":"White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals","volume":"45","author":"Kulkarni","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"key20230925111246_b57-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/cancers11060852","article-title":"Liquid biopsy approach for pancreatic ductal adenocarcinoma","volume":"11","author":"Buscail","year":"2019","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b58-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.dld.2018.08.009","article-title":"Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future","volume":"50","author":"Barhli","year":"2018","journal-title":"Dig Liver Dis"},{"key":"key20230925111246_b59-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.suronc.2018.11.019","article-title":"Pancreatic ductal adenocarcinoma harboring microsatellite instability\/DNA mismatch repair deficiency. Towards personalized medicine","volume":"28","author":"Lupinacci","year":"2019","journal-title":"Surg Oncol"},{"key":"key20230925111246_b60-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.21037\/jgo-20-250","article-title":"Neoadjuvant treatment of localized pancreatic adenocarcinoma","volume":"12","author":"Leal","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"key20230925111246_b61-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.3390\/jcm10225463","article-title":"Simple serum pancreatic ductal adenocarcinoma (PDAC) Protein Biomarkers-Is There Anything in Sight?","volume":"10","author":"Kapszewicz","year":"2021","journal-title":"J Clin Med"},{"key":"key20230925111246_b62-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"175883592110458","DOI":"10.1177\/17588359211045861","article-title":"Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma","volume":"13","author":"Iyengar","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"key20230925111246_b63-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/cancers11010113","article-title":"Prognostic Role of High-Grade tumor budding in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis with a focus on epithelial to mesenchymal transition","volume":"11","author":"Lawlor","year":"2019","journal-title":"Cancers"},{"key":"key20230925111246_b64-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12885-020-07733-0","article-title":"Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: A systematic review","volume":"21","author":"O'Connor","year":"2021","journal-title":"BMC Cancer"},{"key":"key20230925111246_b65-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/heq.2019.0099","article-title":"Same chance of accessing resection? impact of socioeconomic status on resection rates among patients with pancreatic adenocarcinoma-A systematic review","volume":"5","author":"Thobie","year":"2021","journal-title":"Health Equity"},{"key":"key20230925111246_b66-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.2147\/OTT.S323811","article-title":"Surgical resection of pancreatic hepatoid carcinoma followed by combined transarterial chemoembolization and immunotherapy: A case report","volume":"14","author":"He","year":"2021","journal-title":"Onco Targets Ther"},{"key":"key20230925111246_b67-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s40792-019-0723-5","article-title":"Pure pancreatic hepatoid carcinoma: A surgical case report and literature review","volume":"5","author":"Tomino","year":"2019","journal-title":"Surg Case Rep"},{"key":"key20230925111246_b68-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4251\/wjgo.v13.i6.472","article-title":"Current controversies and advances in the management of pancreatic adenocarcinoma","volume":"13","author":"Zeeshan","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"key20230925111246_b69-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.3399\/bjgp13X663244","article-title":"Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria","volume":"63","author":"Gholap","year":"2013","journal-title":"Br J Gen Pract"},{"key":"key20230925111246_b70-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"105951","DOI":"10.1016\/j.ijscr.2021.105951","article-title":"Mixed pancreatic hepatoid carcinoma: A surgical case report and literature review","volume":"83","author":"Trinh","year":"2021","journal-title":"Int J Surg Case Rep"},{"key":"key20230925111246_b71-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00428-006-0353-8","article-title":"Hepatocellular carcinoma arising from ectopic liver tissue in the pancreas","volume":"450","author":"Cardona","year":"2007","journal-title":"Virchows Arch"},{"key":"key20230925111246_b72-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.3748\/wjg.v13.i31.4270","article-title":"Ectopic hepatocellular carcinoma arising from pancreas: A case report and review of the literature","volume":"13","author":"Kubota","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20230925111246_b73-ol-26-4-14029","first-page":"35462","article-title":"Hepatoid carcinoma of the pancreas combined with serous cystadenoma: A case report and review of the literature","volume":"4","author":"Veerankutty","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"key":"key20230925111246_b74-ol-26-4-14029","first-page":"59","article-title":"Oesophageal hepatoid carcinoma with liver metastasis, a diagnostic dilemma","volume":"41","author":"Yahaya","year":"2019","journal-title":"Malays J Pathol"},{"key":"key20230925111246_b75-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.3748\/wjg.v21.i20.6384","article-title":"Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection","volume":"21","author":"Schneitler","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20230925111246_b76-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13014-019-1345-6","article-title":"Pancreatic ductal adenocarcinoma: Biological hallmarks, current status, and future perspectives of combined modality treatment approaches","volume":"14","author":"Orth","year":"2019","journal-title":"Radiat Oncol"},{"key":"key20230925111246_b77-ol-26-4-14029","first-page":"JCO2001364","article-title":"Metastatic pancreatic cancer: ASCO guideline update","author":"Sohal","year":"2020","journal-title":"J Clin Oncol"},{"key":"key20230925111246_b78-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3892\/or_00000919","article-title":"One Year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin","volume":"24","author":"Brown","year":"2010","journal-title":"Oncol Rep"},{"key":"key20230925111246_b79-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12957-015-0586-6","article-title":"Hepatoid carcinoma of the pancreas","volume":"13","author":"Kuo","year":"2015","journal-title":"World J Surg Oncol"},{"key":"key20230925111246_b80-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1148\/rg.2020190184","article-title":"Pancreatic ductal adenocarcinoma and its variants: Pearls and perils","volume":"40","author":"Schawkat","year":"2020","journal-title":"Radiographics"},{"key":"key20230925111246_b81-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/1066896918783468","article-title":"Primary hepatoid carcinoma of the pancreas: A Clinicopathological study of 3 cases with review of additional 31 cases in the literature","volume":"27","author":"Yang","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"key20230925111246_b82-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/PAS.0000000000001588","article-title":"Hepatoid teratoma, hepatoid yolk sac tumor, and hepatocellular carcinoma: A morphologic and immunohistochemical study of 30 cases","volume":"45","author":"Al-Obaidy","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"key20230925111246_b83-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3748\/wjg.v19.i3.321","article-title":"Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: A literature review","volume":"19","author":"Su","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20230925111246_b84-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"219","DOI":"10.21873\/cgp.20033","article-title":"Cytokeratin 18-associated Histone 3 modulation in hepatocellular carcinoma: A mini review","volume":"14","author":"Lai","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"key20230925111246_b85-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1365-2559.2000.00932.x","article-title":"Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver","volume":"37","author":"Shimonishi","year":"2000","journal-title":"Histopathology"},{"key":"key20230925111246_b86-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.prp.2012.01.003","article-title":"Aberrant pattern of the cytokeratin 7\/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations","volume":"208","author":"Gurzu","year":"2012","journal-title":"Pathol Res Pract"},{"key":"key20230925111246_b87-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/1078-0432.CCR-19-1247","article-title":"Predicted prognosis of patients with pancreatic cancer by machine learning","volume":"26","author":"Yokoyama","year":"2020","journal-title":"Clin Cancer Res"},{"key":"key20230925111246_b88-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1600-0560.2006.00593.x","article-title":"Cutaneous clear cell squamous cell carcinoma in situ: Clinical, histological and immunohistochemical characterization","volume":"34","author":"Al-Arashi","year":"2007","journal-title":"J Cutan Pathol"},{"key":"key20230925111246_b89-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1053\/hupa.2000.9843","article-title":"Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: Implications in tumor diagnosis","volume":"31","author":"Miettinen","year":"2000","journal-title":"Hum Pathol"},{"key":"key20230925111246_b90-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.5858\/2002-126-1480-TAIHPA","article-title":"Trophoblast apoptosis in human placenta at term as detected by expression of a cytokeratin 18 degradation product of caspase","volume":"126","author":"Austgulen","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"key20230925111246_b91-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/00000478-200112000-00001","article-title":"Differential expression of mucin genes in mammary and extramammary Paget's disease","volume":"25","author":"Kuan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"key20230925111246_b92-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00018-022-04392-1","article-title":"Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR\/ERK1\/2\/AKT\/mTOR cascade","volume":"79","author":"Kirtonia","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"key20230925111246_b93-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.surg.2012.07.020","article-title":"Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101","volume":"152","author":"Qazi","year":"2012","journal-title":"Surgery"},{"key":"key20230925111246_b94-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3906\/biy-1912-60","article-title":"E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic cancer cells","volume":"44","author":"\u00c7oban","year":"2020","journal-title":"Turk J Biol"},{"key":"key20230925111246_b95-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/modpathol.2011.74","article-title":"Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas","volume":"24","author":"Hong","year":"2011","journal-title":"Mod Pathol"},{"key":"key20230925111246_b96-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"16505","DOI":"10.18632\/oncotarget.7663","article-title":"Aberrant expression of nuclear HDAC3 and cytoplasmic CDH1 predict a poor prognosis for patients with pancreatic cancer","volume":"7","author":"Jiao","year":"2016","journal-title":"Oncotarget"},{"key":"key20230925111246_b97-ol-26-4-14029","first-page":"5753","article-title":"Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20230925111246_b98-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"18056","DOI":"10.1038\/s41598-017-18438-z","article-title":"Worsened outcome in patients with pancreatic ductal carcinoma on long-term diabetes: Association with E-cadherin1 (CDH1) promoter methylation","volume":"7","author":"Saito","year":"2017","journal-title":"Sci Rep |"},{"key":"key20230925111246_b99-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/cancers10090328","article-title":"Clinical impact of Epithelial-to-Mesenchymal transition regulating MicroRNAs in pancreatic ductal adenocarcinoma","volume":"10","author":"Dhayat","year":"2018","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b100-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"107948","DOI":"10.1371\/journal.pone.0107948","article-title":"SMAD4 regulates cell motility through transcription of N-Cadherin in human pancreatic ductal epithelium","volume":"9","author":"Kang","year":"2014","journal-title":"PLoS One"},{"key":"key20230925111246_b101-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.humpath.2011.06.008","article-title":"Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report","volume":"43","author":"Ottenhof","year":"2012","journal-title":"Hum Pathol"},{"key":"key20230925111246_b102-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"10560","DOI":"10.1111\/jcmm.15676","article-title":"Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21\/ZEB-1 pathway","volume":"24","author":"Zhou","year":"2020","journal-title":"J Cell Mol Med"},{"key":"key20230925111246_b103-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.18632\/oncotarget.23929","article-title":"Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma","volume":"9","author":"Hu","year":"2018","journal-title":"Oncotarget"},{"key":"key20230925111246_b104-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/jso.23020","article-title":"Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer","volume":"105","author":"Kurahara","year":"2012","journal-title":"J Surg Oncol"},{"key":"key20230925111246_b105-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"18643","DOI":"10.1074\/jbc.M113.467787","article-title":"Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development","volume":"288","author":"Vannier","year":"2013","journal-title":"J Biol Chem"},{"key":"key20230925111246_b106-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.3892\/mmr.2015.4031","article-title":"Upregulation of microRNA-138-5p inhibits pancreatic cancer cell migration and increases chemotherapy sensitivity","volume":"12","author":"Yu","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20230925111246_b107-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12885-017-3225-5","article-title":"Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer","volume":"17","author":"Lerbs","year":"2017","journal-title":"BMC Cancer"},{"key":"key20230925111246_b108-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"S750","DOI":"10.1245\/s10434-014-3946-5","article-title":"Epithelial-to-Mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes","volume":"21","author":"Lahat","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"key20230925111246_b109-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1517\/14728222.2014.978860","article-title":"The SIX1-EYA transcriptional complex as a therapeutic target in cancer","volume":"19","author":"Blevins","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"key20230925111246_b110-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/labinvest.2016.109","article-title":"Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer","volume":"96","author":"Nomura","year":"2016","journal-title":"Lab Invest"},{"key":"key20230925111246_b111-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.clinimag.2015.04.017","article-title":"Pearls and pitfalls of imaging metastatic disease from pancreatic adenocarcinoma: A systematic review","volume":"39","author":"Zaheer","year":"2015","journal-title":"Clin Imaging"},{"key":"key20230925111246_b112-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3892\/ol.2021.12507","article-title":"Place of hyperthermic intraperitoneal chemotherapy in the armament against pancreatic adenocarcinoma: A survival, mortality and morbidity systematic review","volume":"21","author":"Larentzakis","year":"2021","journal-title":"Oncol Lett"},{"key":"key20230925111246_b113-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2147\/CMAR.S145722","article-title":"Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: A population-based study","volume":"9","author":"Tao","year":"2017","journal-title":"Cancer Manag Res"},{"key":"key20230925111246_b114-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3892\/ol.2021.12507","article-title":"Place of hyperthermic intraperitoneal chemotherapy in the armament against pancreatic adenocarcinoma: A survival, mortality and morbidity systematic review","volume":"21","author":"Larentzakis","year":"2021","journal-title":"Oncol Lett"},{"key":"key20230925111246_b115-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10585-021-10074-2","article-title":"The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: A systematic review","volume":"38","author":"Brind'Amour","year":"2021","journal-title":"Clin Exp Metastasis"},{"key":"key20230925111246_b116-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/cancers11070991","article-title":"Surgery for recurrent pancreatic cancer: Is it effective?","volume":"11","author":"Moletta","year":"2019","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b117-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12032-022-01764-2","article-title":"Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: Two sides of the moon","volume":"39","author":"La Salvia","year":"2022","journal-title":"Med Oncol"},{"key":"key20230925111246_b118-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/j.seminoncol.2014.12.008","article-title":"Neoadjuvant therapy for Non-metastatic pancreatic ductal adenocarcinoma","volume":"42","author":"Winner","year":"2015","journal-title":"Semin Oncol"},{"key":"key20230925111246_b119-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13304-021-01089-1","article-title":"Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma following induction therapy: A systematic review of the published literature","volume":"74","author":"Zhou","year":"2022","journal-title":"Updates Surg"},{"key":"key20230925111246_b120-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21873\/invivo.12229","article-title":"Circulating tumor cells, circulating tumor DNA and other blood-based prognostic scores in pancreatic ductal adenocarcinoma-mini-review","volume":"35","author":"Liberko","year":"2021","journal-title":"In Vivo"},{"key":"key20230925111246_b121-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/MPA.0000000000001694","article-title":"Treatment strategies for the optimal management of locally advanced pancreatic adenocarcinoma with curative intent: A systematic review","volume":"49","author":"Attard","year":"2020","journal-title":"Pancreas"},{"key":"key20230925111246_b122-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.clcc.2014.09.005","article-title":"FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: The royal marsden experience","volume":"13","author":"Moorcraft","year":"2014","journal-title":"Clin Colorectal Cancer"},{"key":"key20230925111246_b123-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1245\/s10434-020-08658-5","article-title":"Predictors for survival in an international cohort of patients undergoing distal pancreatectomy for pancreatic ductal adenocarcinoma","volume":"28","author":"Korrel","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"key20230925111246_b124-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3390\/cancers12071976","article-title":"The impact on survival and morbidity of Portal-Mesenteric resection during pancreaticoduodenectomy for pancreatic head adenocarcinoma: A systematic review and meta-analysis of comparative studies","volume":"12","author":"Fancellu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b125-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijsu.2017.12.032","article-title":"Laparoscopic versus open pancreatectomy for pancreatic ductal adenocarcinoma: A systematic review and meta-analysis","volume":"53","author":"Chen","year":"2018","journal-title":"Int J Surg"},{"key":"key20230925111246_b126-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.ejso.2018.07.047","article-title":"Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?","volume":"44","author":"de Liguori Carino","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"key20230925111246_b127-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41598-018-37617-0","article-title":"The oncological safety in minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: A systematic review and meta-analysis","volume":"9","author":"Yang","year":"2019","journal-title":"Sci Rep"},{"key":"key20230925111246_b128-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.amjms.2016.12.006","article-title":"Metastatic hepatoid carcinoma of the pancreas: First description of treatment with capecitabine and temozolomide","volume":"353","author":"Ferreira","year":"2017","journal-title":"Am J Med Sci"},{"key":"key20230925111246_b129-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.3390\/ijms20184543","article-title":"Current clinical strategies of pancreatic cancer treatment and open molecular questions","volume":"20","author":"Brunner","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20230925111246_b130-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fonc.2020.00245","article-title":"Neoadjuvant treatment in pancreatic cancer","volume":"10","author":"Oba","year":"2020","journal-title":"Front Oncol"},{"key":"key20230925111246_b131-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1002\/cncr.30342","article-title":"Current management and future directions in metastatic pancreatic adenocarcinoma: Review of metastatic pancreatic adenocarcinoma","volume":"122","author":"Varghese","year":"2016","journal-title":"Cancer"},{"key":"key20230925111246_b132-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/MJT.0b013e31819dc8ed","article-title":"Metastatic pancreatic adenocarcinoma: Current standards, future directions","volume":"17","author":"Duffy","year":"2010","journal-title":"Am J Ther"},{"key":"key20230925111246_b133-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.3390\/biomedicines10123196","article-title":"Where do we stand with immunotherapy for advanced pancreatic ductal adenocarcinoma: A synopsis of clinical outcomes","volume":"10","author":"Akhuba","year":"2022","journal-title":"Biomedicines"},{"key":"key20230925111246_b134-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4999\/uhod.1142","article-title":"Current treatment options for metastatic pancreatic adenocarcinoma","volume":"25","author":"Sendur","year":"2015","journal-title":"UHOD"},{"key":"key20230925111246_b135-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1684\/bdc.2011.1494","article-title":"Chemotherapy of metastatic pancreatic adenocarcinoma: Challenges and encouraging results","volume":"98","author":"Conroy","year":"2011","journal-title":"Bull Cancer"},{"key":"key20230925111246_b136-ol-26-4-14029","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"key20230925111246_b137-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1007\/s12094-020-02372-0","article-title":"Potential biomarkers for early detection of pancreatic ductal adenocarcinoma","volume":"22","author":"Kriz","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"key20230925111246_b138-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12935-022-02640-9","article-title":"Advances in biomarkers and techniques for pancreatic cancer diagnosis","volume":"22","author":"Wu","year":"2022","journal-title":"Cancer Cell Int"},{"key":"key20230925111246_b139-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1158\/1078-0432.CCR-10-0248","article-title":"Serum biomarker panels for the detection of pancreatic cancer","volume":"17","author":"Brand","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20230925111246_b140-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"020707","DOI":"10.11613\/BM.2019.020707","article-title":"Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: A pilot study","volume":"29","author":"Tartaglione","year":"2019","journal-title":"Biochem Med (Zagreb)"},{"key":"key20230925111246_b141-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"e0251656","DOI":"10.1371\/journal.pone.0251656","article-title":"PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma","volume":"16","author":"Tartaglione","year":"2021","journal-title":"PLoS One"},{"key":"key20230925111246_b142-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/jgh3.12720","article-title":"Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis","volume":"6","author":"Chan","year":"2022","journal-title":"JGH Open"},{"key":"key20230925111246_b143-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/jhbp.109","article-title":"Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma","volume":"21","author":"Okada","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"key20230925111246_b144-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12328-019-00965-z","article-title":"Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX","volume":"12","author":"Ozaki","year":"2019","journal-title":"Clin J Gastroenterol"},{"key":"key20230925111246_b145-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1245\/s10434-019-07981-w","article-title":"Novel prognostic implications of DUPAN-2 in the era of initial systemic therapy for pancreatic cancer","volume":"27","author":"Sunagawa","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"key20230925111246_b146-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ags3.12629","article-title":"Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma","volume":"7","author":"Takagi","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"key":"key20230925111246_b147-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000449041","article-title":"Serum SPan-1 is a significant risk factor for early recurrence of pancreatic cancer after curative resection","volume":"34","author":"Hosokawa","year":"2017","journal-title":"Dig Surg"},{"key":"key20230925111246_b148-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12957-016-1078-z","article-title":"Preoperative predictors for early recurrence of resectable pancreatic cancer","volume":"15","author":"Nishio","year":"2017","journal-title":"World J Surg Oncol"},{"key":"key20230925111246_b149-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.pan.2012.07.009","article-title":"Monitoring of CA19-9 and SPan-1 can facilitate the earlier confirmation of progressing pancreatic cancer during chemotherapy","volume":"12","author":"Tsutsumi","year":"2012","journal-title":"Pancreatology"},{"key":"key20230925111246_b150-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/000313481808400130","article-title":"Span-1 and CA19-9 as predictors of early recurrence and lymph node metastasis for patients with invasive pancreatic cancer after pancreatectomy","volume":"84","author":"Shimizu","year":"2018","journal-title":"Am Surg"},{"key":"key20230925111246_b151-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.pan.2020.07.011","article-title":"Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma","volume":"20","author":"Inokuchi","year":"2020","journal-title":"Pancreatology"},{"key":"key20230925111246_b152-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1245\/s10434-020-09022-3","article-title":"Prognostic value of the preoperative tumor marker index in resected pancreatic ductal adenocarcinoma: A retrospective single-institution study","volume":"28","author":"Miyata","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"key20230925111246_b153-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1245\/s10434-021-10866-6","article-title":"Development of a biomarker-based scoring system predicting early recurrence of resectable pancreatic duct adenocarcinoma","volume":"29","author":"Ishido","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"key20230925111246_b154-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pan.2016.10.004","article-title":"Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma","volume":"17","author":"Kondo","year":"2017","journal-title":"Pancreatology"},{"key":"key20230925111246_b155-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcancer.2018.04.004","article-title":"Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset","volume":"55","author":"Ho","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"key20230925111246_b156-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s41416-022-01745-2","article-title":"Circulating tumour DNA: A challenging innovation to develop \u2018precision onco-surgery\u2019 in pancreatic adenocarcinoma","volume":"126","author":"Pietrasz","year":"2022","journal-title":"Br J Cancer"},{"key":"key20230925111246_b157-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3390\/cancers14082027","article-title":"Circulating nucleic acids as novel biomarkers for pancreatic ductal adenocarcinoma","volume":"14","author":"McGowan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20230925111246_b158-ol-26-4-14029","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/jso.25851","article-title":"Does neoadjuvant therapy for pancreatic head adenocarcinoma increase postoperative morbidity? A systematic review of the literature with meta-analysis","volume":"121","author":"Araujo","year":"2020","journal-title":"J Surg Oncol"},{"key":"key20230925111246_b159-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/00000478-200209000-00012","article-title":"Cytokeratin expression in adenocarcinomas of the esophagogastric junction: A comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach","volume":"26","author":"Taniere","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"key20230925111246_b160-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.humpath.2003.12.007","article-title":"Cytokeratin expression profile in gastric carcinomas","volume":"35","author":"Kim","year":"2004","journal-title":"Hum Pathol"},{"key":"key20230925111246_b161-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.3748\/wjg.v11.i41.6530","article-title":"Correlation between CK18 gene and gastric carcinoma micrometastasis","volume":"11","author":"Xu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"key20230925111246_b162-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1097\/01.pas.0000135520.72965.50","article-title":"Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine","volume":"28","author":"Chen","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"key20230925111246_b163-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/00365520600554469","article-title":"RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients","volume":"41","author":"Kelder","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"key20230925111246_b164-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000325684","article-title":"Cytokeratin 8 and 18 expression in imprint smears of chronic viral hepatitis, autoimmune hepatitis and hepatocellular carcinoma","volume":"51","author":"Athanassiadou","year":"2007","journal-title":"Acta Cytologica"},{"key":"key20230925111246_b165-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/00000478-200310000-00002","article-title":"Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: An immunohistochemical and molecular study of eight cases","volume":"27","author":"Terracciano","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"key20230925111246_b166-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1078\/0344-0338-00356","article-title":"Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract","volume":"199","author":"Cabibi","year":"2003","journal-title":"Pathol Res Pract"},{"key":"key20230925111246_b167-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00004347-200201000-00002","article-title":"Distinction between endometrial and endocervical adenocarcinoma: An immunohistochemical study","volume":"21","author":"Castrillon","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"key20230925111246_b168-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/modpathol.3880175","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases","volume":"13","author":"Chu","year":"2000","journal-title":"Mod Pathol"},{"key":"key20230925111246_b169-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.pas.0000213281.43036.bb","article-title":"Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: Analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases","volume":"30","author":"Vang","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"key20230925111246_b170-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00004347-199904000-00005","article-title":"Immunophenotype of transitional metaplasia of the uterine cervix","volume":"18","author":"Harnden","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"key20230925111246_b171-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1092-9134(99)80013-6","article-title":"Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases","volume":"3","author":"Tot","year":"1999","journal-title":"Ann Diagn Pathol"},{"key":"key20230925111246_b172-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1309\/WP3QWKVJFYDHHXQD","article-title":"Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples","volume":"123","author":"Cruz","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"key20230925111246_b173-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12105-016-0694-9","article-title":"Sinonasal adenocarcinoma: Update on classification, immunophenotype and molecular features","volume":"10","author":"Leivo","year":"2016","journal-title":"Head Neck Pathol"},{"key":"key20230925111246_b174-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00129039-200009000-00004","article-title":"Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms","volume":"8","author":"Bejarano","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20230925111246_b175-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2407-6-31","article-title":"Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer","volume":"6","author":"Ikeda","year":"2006","journal-title":"BMC Cancer"},{"key":"key20230925111246_b176-ol-26-4-14029","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1053\/hupa.2002.129416","article-title":"Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma","volume":"33","author":"Mhawech","year":"2002","journal-title":"Hum Pathol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T04:13:00Z","timestamp":1695615180000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2023.14029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":176,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,28]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2023.14029","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"article-number":"442"}}